Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Periodontal Diseases

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Periodontal Diseases in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Periodontal Diseases: Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noguchi, K1
Endo, H1
Kondo, H1
Ishikawa, I1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Periodontal Diseases

ArticleYear
Prostaglandin F2alpha upregulates interleukin-6 production in human gingival fibroblasts.
    Journal of periodontal research, 2001, Volume: 36, Issue:2

    Topics: Calcium; Calcium Channel Blockers; Cells, Cultured; Dinoprost; Dose-Response Relationship, Drug; Dow

2001